Press release
March 10, 2026
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
CRISPR Therapeutics AG (CRSP)
ZUG, Switzerland and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced its intention to offer, subject to market conditions and other factors, $350 million aggregate principal amount of its convertible senior notes due 2031 (the